These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Timing of antiretroviral drugs during tuberculosis therapy. Wilson D; Meintjes G N Engl J Med; 2010 Jun; 362(22):2137; author reply 2138-9. PubMed ID: 20519688 [No Abstract] [Full Text] [Related]
25. Progressive symptoms and signs following institution of highly active antiretroviral therapy and subsequent antituberculosis therapy: immune reconstitution syndrome or infection? Miller RF; Shahmanesh M; Talbot MD; Wiselka MJ; Shaw PJ; Bacon C; Robertson CM Sex Transm Infect; 2006 Apr; 82(2):111-6. PubMed ID: 16581733 [TBL] [Abstract][Full Text] [Related]
26. Cutaneous reactions to thiacetazone in Zambia--implications for tuberculosis treatment strategies. Kelly P; Buve A; Foster SD; McKenna M; Donnelly M; Sipatunyana G Trans R Soc Trop Med Hyg; 1994; 88(1):113-5. PubMed ID: 7512287 [TBL] [Abstract][Full Text] [Related]
27. [Tuberculosis in the year 2000]. Martínez Cruz R; Alvarez-Sala JL An Med Interna; 1999 Feb; 16(2):57-8. PubMed ID: 10192994 [No Abstract] [Full Text] [Related]
28. When should antiretroviral treatment be started in patients with HIV-associated tuberculosis in South Africa? Lawn SD; Wood R S Afr Med J; 2007 Jun; 97(6):412, 414-5. PubMed ID: 17691468 [No Abstract] [Full Text] [Related]
29. Concurrent ART/TB treatment finally proven to be beneficial. Ryan CT AIDS Clin Care; 2008 Nov; 20(11):89. PubMed ID: 19170252 [TBL] [Abstract][Full Text] [Related]
30. [Cutaneous reactions to thiacetazone (TB1) (author's transl)]. Strobel M; Ndiaye B; Marchand JP; Jovet JC Rev Fr Mal Respir; 1979; 7(5):467-70. PubMed ID: 95055 [TBL] [Abstract][Full Text] [Related]
31. Tuberculosis and HIV disease. Johnson MP; Chaisson RE AIDS Clin Rev; 1993-1994; ():73-93. PubMed ID: 8217905 [No Abstract] [Full Text] [Related]
32. Drugs for tuberculosis. Treat Guidel Med Lett; 2009 Oct; 7(86):75-82; quiz 2 p after 82. PubMed ID: 19794340 [No Abstract] [Full Text] [Related]
33. Playing god in Kathmandu. Kafle R GMHC Treat Issues; 2005; 19(5-6):15. PubMed ID: 16193579 [No Abstract] [Full Text] [Related]
35. [The mechanisms of Mycobacterium tuberculosis disease and the implications for its prevention in patients with HIV infection]. Díez Ruiz-Navarro M; del Amo Valero J Med Clin (Barc); 1999 Jul; 113(4):150-5. PubMed ID: 10472601 [No Abstract] [Full Text] [Related]
36. Issues in the management of HIV-related tuberculosis. Burman WJ Clin Chest Med; 2005 Jun; 26(2):283-94, vi-vii. PubMed ID: 15837111 [TBL] [Abstract][Full Text] [Related]
37. [Tuberculosis in HIV infection]. Karachunskiĭ MA Probl Tuberk; 2000; (1):47-52. PubMed ID: 10809636 [No Abstract] [Full Text] [Related]
38. NIAID study finds initial intermittent treatment effective for HIV-related TB. AIDS Patient Care STDS; 1996 Dec; 10(6):381-2. PubMed ID: 11361574 [No Abstract] [Full Text] [Related]
39. Complications in HIV treatment. TB and co-infection news from IAS. Farrand B Posit Aware; 2007; 18(6):17-8. PubMed ID: 18074428 [No Abstract] [Full Text] [Related]
40. [Skin toxicity of thiacetazone (TB1) at a hospital service in Dakar]. Dieng MT; Ndiaye B; Camara C Dakar Med; 2001; 46(1):1-3. PubMed ID: 15773145 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]